Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):945-58. doi: 10.1016/j.beem.2011.07.009.
Despite improved obstetric surveillance and better management of maternal hyperglycaemia over the last few decades, perinatal mortality and congenital malformation rates remain several fold higher in pregnancy complicated by diabetes than in the background population. A worldwide increase in the prevalence of type 2 diabetes is now being realized in the pregnancy context with apparently similar or even worse outcomes to type 1 diabetes. While the relevance of periconceptual glycaemic control to maternal fetal outcome is clearly established, only around half of women with type 1 diabetes plan their pregnancy and rates are even lower in type 2 diabetes. In the last 5-10 years, several landmark trials have pointed to the validity of gestational diabetes mellitus as a diagnostic entity, however translation of recently published consensus guidelines for diagnosis and screening into routine clinical practice may prove challenging. An expanding therapeutic armamentarium and increasing awareness of the long-term implications of diabetic pregnancy for both mother and child present new challenges for clinical care, research and public health.
尽管在过去几十年中,产科监测得到了改善,孕妇高血糖的管理也得到了改善,但妊娠合并糖尿病的围产儿死亡率和先天畸形率仍比背景人群高出数倍。目前,全球范围内 2 型糖尿病的患病率呈上升趋势,在妊娠中表现出与 1 型糖尿病类似甚至更差的结局。虽然妊娠前血糖控制与母婴结局的相关性已得到明确证实,但只有大约一半的 1 型糖尿病女性计划妊娠,而 2 型糖尿病的比例甚至更低。在过去的 5-10 年中,几项具有里程碑意义的试验表明,妊娠期糖尿病作为一种诊断实体是有效的,然而,将最近发表的诊断和筛查共识指南转化为常规临床实践可能具有挑战性。治疗手段的不断增加,以及对糖尿病妊娠对母婴长期影响的认识不断提高,为临床护理、研究和公共卫生带来了新的挑战。